Pronova BioPharma appoints Per-Oluf Olsen as new CEO
Pronova BioPharma ASA announced that the board of directors has appointed Per-Oluf Olsen as chief executive officer to succeed Tomas Settevik, who has informed the board that he wishes to stand down from his position as CEO.
Per-Oluf Olsen, aged 52, will assume the role of CEO with effect from 17 November 2008. He joins Pronova BioPharma after 27 years with Pfizer Inc., where he gained extensive international experience in sales, marketing and management. Most recently, Mr. Olsen was regional executive director for Central and Eastern European region, inclusive regional office in Brussels. He was previously country manager for Pfizer in Italy, Norway and Denmark and has held a number of senior sales and marketing positions for the company in Norway and the USA.
Tomas Settevik will be proposed to be elected as a new board member at the annual general meeting in May 2009.
Other news from the department people
